Analyses of Japanese patients recruited in IPASS, a phase III, randomized, open-label, first-line study of gefitinib vs carboplatin/paclitaxel in selected pts with advanced non-small-cell lung cancer
JOURNAL OF THORACIC ONCOLOGY(2009)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined